Jennifer Leohr

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Topics

Placebo Controlled

Top Venues

Diabetes, obesity & metabolism

CPT: pharmacometrics & systems pharmacology

Journal of pharmacokinetics and pharmacodynamics

Pharmaceutical research

This page only lists publications with an associated author ORCID identifier.

Publications

Ronnie Aronson, Torben Biester, Jennifer Leohr, Robyn K Pollom, Helle Linnebjerg, Elizabeth Smith LaBell, Qianyi Zhang, David E Coutant, Thomas Danne
Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents, and adults with type 1 diabetes mellitus. Diabetes, obesity & metabolism (2023)
Jennifer Leohr, Maria C Kjellsson
Evaluation of postprandial total triglycerides within the TIGG model for characterizing postprandial response of glucose, insulin, and GLP-1. CPT: pharmacometrics & systems pharmacology (2023)
Jennifer Leohr, Mary Anne Dellva, Elizabeth LaBell, David E Coutant, Jorge Arrubla, Leona Plum-Mörschel, Eric Zijlstra, Tsuyoshi Fukuda, Thomas Hardy
Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusion. Diabetes, obesity & metabolism (2023)
Jennifer Leohr, Christof Kazda, Rong Liu, Shobha Reddy, Mary Anne Dellva, Mark Matzopoulos, Mei Teng Loh, Thomas Hardy, Oliver Klein, Christoph Kapitza
Ultra rapid lispro (URLi) shows faster pharmacokinetics and reduces postprandial glucose excursions versus Humalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early-phase study. Diabetes, obesity & metabolism (2021)
Jennifer Leohr, Michael Heathman, Maria C Kjellsson
Postprandial triglyceride reduction following acute treatment of a selective 5-hydroxytryptamine-2c agonist and characterization using a semi-physiological model. Diabetes, obesity & metabolism 23 (4) (2021)
Christof Kazda, Jennifer Leohr, Rong Liu, Shobha Reddy, Mary Anne Dellva, Mei Teng Loh, Thomas Hardy, Leona Plum-Mörschel
Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double-blind meal test early-phase study. Diabetes, obesity & metabolism (2021)
Jennifer Leohr, Maria C Kjellsson
Linking categorical models for prediction of pleasantness score using individual predictions of sweetness and creaminess: An advancement of categorical modeling. Journal of pharmacokinetics and pharmacodynamics 48 (6) (2021)
Jennifer Leohr, Maria C Kjellsson
Sweet/Fat Preference Taste in Subjects Who are Lean, Obese and Very Obese. Pharmaceutical research 37 (12) (2020)
Tim Heise, Helle Linnebjerg, David Coutant, Elizabeth LaBell, Eric Zijlstra, Christoph Kapitza, Juliana M Bue-Valleskey, Qianyi Zhang, Mary Anne Dellva, Jennifer Leohr
Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study. Diabetes, obesity & metabolism 22 (10) (2020)
Jennifer Leohr, Michael Heathman, Maria C Kjellsson
Semi-physiological model of postprandial triglyceride response in lean, obese and very obese individuals after a high-fat meal. Diabetes, obesity & metabolism 20 (3) (2017)